- Home
- OPT vs FUBO Comparison
OPT vs FUBO Comparison
Compare OPT & FUBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPT
- FUBO
- Stock Information
- Founded
- OPT 1984
- FUBO 2009
- Country
- OPT Australia
- FUBO United States
- Employees
- OPT N/A
- FUBO N/A
- Industry
- OPT Biotechnology: Biological Products (No Diagnostic Substances)
- FUBO Broadcasting
- Sector
- OPT Health Care
- FUBO Industrials
- Exchange
- OPT Nasdaq
- FUBO Nasdaq
- Market Cap
- OPT 767.9M
- FUBO 681.7M
- IPO Year
- OPT 2020
- FUBO 2020
- Fundamental
- Price
- OPT $3.24
- FUBO $1.51
- Analyst Decision
- OPT Strong Buy
- FUBO Buy
- Analyst Count
- OPT 1
- FUBO 6
- Target Price
- OPT $12.00
- FUBO $2.88
- AVG Volume (30 Days)
- OPT 39.0K
- FUBO 10.3M
- Earning Date
- OPT 08-30-2024
- FUBO 11-01-2024
- Dividend Yield
- OPT N/A
- FUBO N/A
- EPS Growth
- OPT N/A
- FUBO N/A
- EPS
- OPT N/A
- FUBO N/A
- Revenue
- OPT $261,859.00
- FUBO $1,589,700,000.00
- Revenue This Year
- OPT N/A
- FUBO $20.96
- Revenue Next Year
- OPT $46,864.64
- FUBO $10.94
- P/E Ratio
- OPT N/A
- FUBO N/A
- Revenue Growth
- OPT N/A
- FUBO 24.45
- 52 Week Low
- OPT $1.79
- FUBO $1.10
- 52 Week High
- OPT $5.45
- FUBO $3.82
- Technical
- Relative Strength Index (RSI)
- OPT 27.29
- FUBO 47.55
- Support Level
- OPT $4.02
- FUBO $1.39
- Resistance Level
- OPT $4.18
- FUBO $1.49
- Average True Range (ATR)
- OPT 0.22
- FUBO 0.11
- MACD
- OPT -0.13
- FUBO -0.00
- Stochastic Oscillator
- OPT 6.85
- FUBO 26.80
About OPT Opthea Limited
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
About FUBO fuboTV Inc.
FuboTV Inc is a sports-first, live TV streaming company, offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. The company offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality best suited to their preferences. The operating segment of the group is Streaming. It has a business presence in the United States and other international countries.